SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-16-011529
Filing Date
2016-02-05
Accepted
2016-02-05 16:30:53
Documents
4
Period of Report
2016-02-02
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1600342_8k.htm 8-K 18378
2 EXHIBIT 99.1 t1600342_ex99-1.htm EX-99.1 10972
3 GRAPHIC ex99-1logo.jpg GRAPHIC 10119
4 GRAPHIC pg1.jpg GRAPHIC 3538
  Complete submission text file 0001571049-16-011529.txt   49713
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 161392643
SIC: 2834 Pharmaceutical Preparations